How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

    The content on this page is not current guidance and is only for the purposes of the consultation process.

    Transcatheter tricuspid valve implantation for symptomatic severe tricuspid regurgitation

    Closed for comments This consultation ended on at   Request commenting lead permission

    2 Information about the procedure

    2.1

    Transcatheter tricuspid valve implantation is designed to replace the native tricuspid valve in people with symptomatic severe tricuspid valve regurgitation, without the need for open-heart surgery. The procedure is usually done under local or general anaesthesia. An artificial valve is implanted into the existing tricuspid valve. Transfemoral or internal jugular venous access can be used, or the delivery system can be inserted into the right atrium with access through a right anterior lateral thoracotomy in the intercostal space. The valve is positioned within the native tricuspid valve under real-time transoesophageal echocardiography visualisation and fluoroscopy.

    2.2

    Different transcatheter tricuspid valve implantation systems are available. They differ in terms of valve design, size, stent frame, anchoring mechanism and delivery systems.